Pivotal Therapeutics Inc. VASCAZEN® - REVEAL Trial Top Line Results to be presented at American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology 2013 Scientific Sessions
5/1/2013 6:56:08 AM
More...
|
Pivotal Therapeutics Inc. VASCAZEN® - Meets Primary Endpoint in Reveal Trial - Top Line Results Accepted for Presentation at the American Heart Association's ATVB 2013 Scientific Sessions
4/9/2013 9:24:16 AM
More...
|
BG Medicine (BGMD) Announces Data Analyses Presented at American Heart Association Meeting
11/9/2012 9:50:27 AM
More...
|
American Heart Association Release: Total Hip Replacement Surgery May Increase Risk of Stroke
11/9/2012 9:39:13 AM
More...
|
EnteroMedics (ETRMD) Announces EMPOWER Trial Hypertension Data Presented at the American Heart Association's 2012 Scientific Sessions
11/8/2012 8:47:58 AM
More...
|
Heart Failure Patients May Have Increased Cancer Risk, Study Presented at American Heart Association
11/8/2012 8:13:58 AM
More...
|
American Heart Association Release: Cooling Cardiac Arrest Patients to Lower Body Temps Improved Survival
11/7/2012 9:33:48 AM
More...
|
American Heart Association Release: New Drug May Hold Promise for Hospitalized Heart Failure Patients
11/7/2012 9:33:18 AM
More...
|
American Heart Association Release: Ultrafiltration May Not be Best Approach for Heart Failure Patients
11/7/2012 9:32:35 AM
More...
|
VistaGen Therapeutics, Inc. and Duke University Announce Heart Tissue Engineering Progress at American Heart Association 2012 Scientific Sessions
11/7/2012 8:52:23 AM
More...
|
|